RevitaCAM

RSS

meloxicam

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for RevitaCAM has been withdrawn at the request of the marketing authorisation holder.

This EPAR was last updated on 30/05/2016

Authorisation details

Product details
Name
RevitaCAM
Agency product number
EMEA/V/C/002379
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Revision
5
Date of issue of marketing authorisation valid throughout the European Union
23/02/2012
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve
Belgium

Product information

05/10/2015 RevitaCAM - EMEA/V/C/002379 - T/0006

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Oxicams

Therapeutic indication

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders in dogs.

Assessment history

How useful was this page?

Add your rating